Elecoglipron for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Aug 2026: Trial registered, NCT07775404
  2. 21 Aug 2026: Trial started, NCT07775404

The trials

NCT07775404: A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

State
Under way
Phase
Phase 3
People
351 planned
Started
21 Aug 2026
Primary completion
6 Apr 2028
Arms
Arm 1 - Dose 1, Arm 2 - Dose 2
Results
None posted
  1. 20 Aug 2026: Trial registered
  2. 21 Aug 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.